Hopkins expert Thomas Hartung discusses NIH announcement that it will no longer consider grant proposals that do not include alternative testing models| The Hub
A Johns Hopkins team has developed a gene editing approach that could make the treatment of sickle cell disease shorter and less risky, relieving some of the burden on patients| The Hub